An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy

There is ample experimental and clinical evidence that chemotherapies are more efficient if they succeed in (re)activating immune surveillance, hence triggering a long-term immune response against residual tumor cells. Most of the preclinical evidence supporting this notion has been obtained with tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaud, Mickaël, Xie, Xiaoqi, Bravo-San Pedro, José Manuel, Zitvogel, Laurence, White, Eileen, Kroemer, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292732/
https://www.ncbi.nlm.nih.gov/pubmed/25610726
http://dx.doi.org/10.4161/21624011.2014.944047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292732/
https://www.ncbi.nlm.nih.gov/pubmed/25610726
http://dx.doi.org/10.4161/21624011.2014.944047

Ejemplares similares